0
0
In the fight against Corona, AstraZeneca has achieved positive results with an experimental antibody combination in a study.
According to the results, the antibody combination reduces the number of seriously ill and dead people among Corona-infected patients, the British pharmaceutical company announced on Monday. Patients who have been symptomatic for seven days or less and do not require hospital treatment have a 50 percent reduction in the risk of becoming seriously ill or dying, it said.
AstraZeneca agreed million-dollar deal for RNA technology
The late-stage trial of the drug, called AZD7442, found that. “Early intervention with our antibody can significantly reduce disease progression and provide protection for more than six months,” explained AstraZeneca manager Mene Pangalos.
The group has already applied to U.S. authorities for emergency approval of the antibody cocktail as a preventive agent, he said.
- source: k.at/picture:tagesschaue.de
This post has already been read 760 times!
